Johnson & Johnson Starts Ebola Vaccine Trial in Sierra Leone

Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study being conducted in that nation's Kambia district, where some of the country's most recent Ebola cases have been reported. More than 11,000 people have died from the Ebola virus since the latest outbreak emerged in late 2013, nearly all of them in West Africa in and around Sierra Leone. There is currently no licensed vaccine, treatment or cure for...

© La Voix de l'Amérique - vendredi 9 octobre 2015